By studying a large number of cancer types, we found that genetic correlates in any single cancer type can be found in other cancer types as well (for example, Nrf2 activation in LUSC, LUAD and hepatobiliary cancer and AR expression in prostate and breast adenocarcinomas). This evidence concerns the gene AR and breast adenocarcinoma.